cytarabine has been researched along with Carcinoma, Transitional Cell in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, K; Barbarotta, L; Gore, SD; Kasberg, S; Kim, TK; Podoltsev, NA; Prebet, T; Roche, K; Stahl, M; Xu, ML; Zeidan, AM | 1 |
| Gill, DS; Hawley, CM; Marlton, PV; Norris, D; Tey, SK | 1 |
| Cobo, ML; Gómez-Román, JJ; Val-Bernal, JF | 1 |
| Buick, RN; Connolly, JG; Jewett, MA; Keresteci, AG; Kovnat, A; Tannock, IF | 1 |
| Kobayashi, T; Maegawa, M; Mishina, T; Nakagawa, S; Nakao, M | 1 |
| Armitage, M; Kovnat, A; Tannock, I | 1 |
| Chen, CL; Horng, YY; Kao, YL; Kuo, JH; Ou, YC; Yang, CR; Yang, CS; Yean, SY | 1 |
| Ariyoshi, A; Fujisawa, Y; Kumazawa, J; Morita, I; Naito, S; Omoto, T; Osada, Y; Sakamoto, N; Yamashita, H | 1 |
| Kagawa, S; Yokota, T | 1 |
| Miura, K; Tsukada, T; Yuri, Y | 1 |
| Hida, S; Okada, K; Ooishi, K; Yamauchi, T; Yoshida, O | 1 |
| Horiuchi, S; Kanaoya, F; Kojima, S; Nakame, Y; Negishi, T; Owada, F; Saito, T; Satake, I; Tari, K; Yoshida, K | 1 |
| Kyriazis, AA; Kyriazis, AP; Royer, GL; Yagoda, A | 1 |
| Iwase, Y; Sakagami, H; Tsugaya, M; Washida, H | 1 |
| Amino, I; Fujieda, J; Koyanagi, T; Kusakai, Y; Maru, A; Nantani, M; Nishida, T; Ohashi, N; Omuro, H; Yamada, T | 1 |
1 review(s) available for cytarabine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Transitional Cell; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Liver Neoplasms; Lymphoma, T-Cell; Methotrexate; Middle Aged; Neoplasms, Second Primary; Postoperative Complications; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Splenic Neoplasms; Urinary Bladder Neoplasms; Vesico-Ureteral Reflux; Vincristine | 2008 |
1 trial(s) available for cytarabine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study.
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Prospective Studies; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2001 |
13 other study(ies) available for cytarabine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Topics: Aged, 80 and over; Antibodies, Bispecific; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Transitional Cell; Cytarabine; Female; Humans; Lymphoma, B-Cell; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Salvage Therapy; Urinary Bladder Neoplasms; Vincristine | 2016 |
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as a bladder neoplasm.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Cytarabine; Diagnosis, Differential; Disease-Free Survival; Etoposide; Humans; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Methylprednisolone; Middle Aged; Mucin-1; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Treatment Outcome; Urinary Bladder Neoplasms | 2008 |
Comparison of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics.
Topics: Animals; Carcinoma, Transitional Cell; Cell Division; Cells, Cultured; Cytarabine; Humans; Male; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Transplantation, Heterologous; Urinary Bladder Neoplasms; Whole-Body Irradiation | 1984 |
Development and clinical application of an AFC regimen (adriamycin, futraful, cytosine arabinoside) for superficial bladder tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Doxorubicin; Female; Humans; Male; Middle Aged; Papilloma; Tegafur; Urinary Bladder Neoplasms | 1983 |
Xenografts of human bladder cancer in immune-deprived mice.
Topics: Animals; Carcinoma, Transitional Cell; Cell Division; Cell Line; Cytarabine; Humans; Immunosuppression Therapy; Lung Neoplasms; Male; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Thymectomy; Transplantation, Heterologous; Urinary Bladder Neoplasms; Whole-Body Irradiation | 1982 |
Intracellular glutathione content of urothelial cancer in correlation to chemotherapy response.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Humans; Male; Middle Aged; Mitoxantrone; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1997 |
[Experimental studies on effects of carcinostatic agents (author's transl)].
Topics: Animals; Bleomycin; Carcinoma, Transitional Cell; Cytarabine; Mitomycins; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Inbred ACI; Transplantation, Homologous; Urinary Bladder Neoplasms | 1975 |
[Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor].
Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder Neoplasms | 1990 |
[Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Cytarabine; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Methotrexate; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Peplomycin; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vincristine | 1985 |
[Prophylactic intravesical chemotherapy in bladder tumors after surgery of upper tract urothelial carcinoma].
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carcinoma, Transitional Cell; Cytarabine; Doxorubicin; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Nephrectomy; Postoperative Period; Ureter; Urinary Bladder Neoplasms; Urologic Neoplasms | 1987 |
Experimental studies on the response of nude mouse-grown human urothelial cancer to high dose of 1-beta-D-arabinofuranosylcytosine.
Topics: Aged; Aged, 80 and over; Animals; Carcinoma, Transitional Cell; Cytarabine; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Random Allocation; Remission Induction; Urinary Bladder Neoplasms | 1988 |
[Our experience with combined intravesical instillation therapy of superficial bladder tumor using Aclacinomycin-A (ACM) and cytosine arabinoside (CA)].
Topics: Aclarubicin; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Evaluation; Female; Humans; Male; Middle Aged; Naphthacenes; Neoplasm Recurrence, Local; Remission Induction; Urinary Bladder Neoplasms | 1987 |
[Prophylactic chemotherapy of transitional cell carcinoma of the bladder: the efficacy of long-term bladder instillation].
Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carcinoma, Transitional Cell; Cytarabine; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms | 1986 |